Love thy neighbors
What the neighbors say
New explanations for old observations: marginal band coiling during platelet activation
Active metabolite concentration of clopidogrel in patients taking different doses of aspirin: results of the interaction trial
Real-world variability in dabigatran levels in patients with atrial fibrillation
Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)
The pharmacokinetics of a B-domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A
Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity
Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality
Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome
Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis
Down in a hole: a new laser ablation model of hemostasis
Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition
Multimodal assessment of non-specific hemostatic agents for apixaban reversal
The balance of pro- and anticoagulant processes underlying thrombin generation
Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate
Recommendations for the assessment of non-extremity venous thromboembolism outcomes: communication from the SSC of the ISTH
Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH
Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis: comment
The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: comment
Corrigendum
Corrigendum
Join the ISTH, the Leading Global Community of Specialists in Thrombosis and Haemostasis